Search

Search Constraints

You searched for: Date 2020 Author/Creator Walewski, Jan

Search Results

1. A roadmap for a comprehensive control of cervical cancer in Poland: integration of available solutions into current practice in primary and secondary prevention. Issue 2 (March 2020)

3. Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortium. Issue 3 (23rd February 2020)

4. Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study. (July 2020)

5. Primary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapy. Issue 12 (14th October 2020)

6. Primary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapy. Issue 12 (14th October 2020)

7. Primary refractory multiple myeloma: a real-world experience with 85 cases. Issue 12 (14th October 2020)

8. Primary refractory multiple myeloma: a real-world experience with 85 cases. Issue 12 (14th October 2020)

9. Significance of CD10 protein expression in the diagnostics of follicular lymphoma: A comparison of conventional immunohistochemistry with flow cytometry supported by the establishment of BCL2 and BCL6 rearrangements. (4th May 2020)